The Cognitive Care Crisis Part 2: The Adherence Gap
In Part 1 of this series, we explored the diagnostic gap in brain health, the reality that most patients with cognitive symptoms never receive a deep investigation into reversible drivers.
But diagnosis alone does not solve the problem.
Even when we identify root causes, another barrier quickly appears.
The adherence gap.
Why Brain Health Is Different
In a conventional drug-based model of disease, adherence is relatively simple.
Take the medication.
The mechanism is straightforward: a drug blocks a pathway, suppresses a signal, or alters a biochemical process.
The patient’s role is largely passive.
But the emerging model of cognitive care, what Dr. Bredesen describes as addressing “network insufficiency” is fundamentally different.
Here, the goal is not to block a pathway.
The goal is to restore biological networks to full function.
That means rebuilding:
metabolic networks
immune networks
detoxification pathways
sleep and circadian rhythms
movement and mitochondrial capacity
emotional and social regulation
Restoring networks requires participation.
Not once.
But consistently.
Health Is Built Through Repetition
The core intervention in network-based medicine is deceptively simple.
Do healthy things consistently.
Eat the right foods.
Move the body.
Sleep properly.
Reduce toxic burden.
Support detoxification pathways.
Take targeted supplements.
Follow therapeutic protocols.
None of these actions are complicated in isolation.
But doing them every day, for months or years, is another matter entirely.
Especially for someone whose brain is already struggling.
Which brings us to an important insight from some of the most promising clinical research in cognitive reversal.
The Role of Support in the Randomized Controlled Trial and Ornish Trial
In the recent preprint for a randomized controlled trial in Alzheimer’s disease, participants followed a KetoFlex dietary protocol, a strategy designed to improve metabolic function and support brain energy systems.
Meanwhile, in the Ornish trial for Alzheimer’s, participants followed a whole-food, plant-based vegan diet, alongside other lifestyle interventions.
These two dietary strategies are very different.
One is low-carbohydrate and metabolically focused.
The other is plant-based and extremely low in fat.
But the key insight is not which diet was used.
The key insight is this:
In both trials, patients had to radically change how they ate.
They had to buy different foods.
Cook different meals.
Follow entirely new dietary rules.
And they had to do it every day.
Not for a week.
Not for a month.
But for months and years.
This is why support structures were built directly into these studies.
In the randomized controlled trial, participants were required to have a supportive family member involved in their care.
This was not optional.
It was part of the protocol.
Why?
Because the researchers understood something essential:
You cannot rebuild biological networks in isolation.
Even one supportive person dramatically increases the likelihood that someone will follow through with the lifestyle and therapeutic changes required.
But in the real world, even that may not be enough.
What many patients actually need is a community of people making the same changes together.
Because regardless of which dietary strategy a clinician chooses: KetoFlex, plant-based, Mediterranean, or another therapeutic diet, the reality is the same.
Patients suddenly need to:
source new ingredients
learn new recipes
change how they cook
prepare meals consistently
sustain the changes week after week
This is not just a dietary intervention.
It is a life infrastructure change.
And infrastructure is very hard to build alone.
Why Community Matters for Adherence
Consider what a precision cognitive care protocol often requires.
A patient may need to:
follow a therapeutic diet
prepare entirely different meals
take supplements multiple times per day
support detoxification pathways
improve sleep and circadian rhythms
increase physical activity
address environmental exposures
attend clinical follow-ups
That is a lot.
And it becomes even more overwhelming for someone experiencing brain fog, memory changes, or executive dysfunction.
Which is why adherence rarely happens through individual willpower alone.
It happens through structure and community.
The Community Cure
In my previous book, The Community Cure, I explored how many of the most powerful health interventions work best when people do them together.
One simple but powerful example is community cooking.
Imagine a group of patients gathering once a week to prepare their healthy meals for the week ahead.
They share recipes.
They cook in bulk.
They support one another.
Instead of struggling alone every evening, the structure already exists.
Adherence becomes dramatically easier.
The same principle applies to:
group exercise
group education
accountability structures
shared progress tracking
Health behaviors are contagious.
But only when networks exist.
Why Clinics Alone Can’t Solve This
Historically, functional medicine clinics have tried to solve the adherence gap themselves.
Many practices now include:
dietitians
health coaches
care coordinators
This is an important step forward.
But it also places enormous pressure on clinics to build infrastructure that goes far beyond traditional medical care.
Because the reality is this:
Some coordination happens in the clinic.
But most coordination happens in the patient’s life.
Remembering supplements morning, noon, and evening.
Preparing meals.
Scheduling movement.
Managing sleep.
Following detoxification protocols.
These daily actions are where outcomes are determined.
Clinical Care Still Matters
Of course, clinical expertise remains essential.
Returning to Dr. Molly Maloof’s story from Part 1 identifying mercury toxicity is only the beginning.
Detoxification is not something most patients can safely or effectively navigate on their own.
It requires careful sequencing.
Mobilizing toxins too aggressively can worsen symptoms.
Clinicians must consider:
liver function
kidney function
bile flow
gut elimination
lymphatic movement
mitochondrial capacity
This is where precision clinical care matters.
But even the best clinical strategy fails if patients cannot implement it.
The Adherence Gap
This is the uncomfortable truth in precision cognitive medicine.
Diagnosis is difficult.
But adherence is harder.
Restoring network sufficiency requires sustained participation across many areas of life.
Without support structures, most patients simply cannot maintain the changes long enough to rebuild biological resilience.
Which is why the future of cognitive care will require something new.
Not just better diagnostics.
Not just better protocols.
But better systems that help people live the interventions consistently.
Building the Infrastructure for Brain Health
The emerging solution will likely combine three elements:
Precision clinical care to identify and treat root causes
Community structures that make healthy behaviors sustainable
Technology platforms that help coordinate daily actions and track progress
This is the infrastructure that has been missing.
And building it may be just as important as discovering the root causes themselves. That is the purpose of TruNeura.
Next in the Series
The cognitive care crisis is not just biological.
It is structural.
In Part 3, we will explore the Economic Gap, the financial incentives that prevent this model of care from scaling.
Because even when diagnosis improves and adherence becomes possible…
The system still has to pay for it.
And right now, it largely doesn’t.
